• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2018
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2018
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Gamma delta T cell therapy for cancer: It is good to be local

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Pauza, C.D.
    Liou, M.-L.
    Lahusen, T.
    Date
    2018
    Journal
    Frontiers in Immunology
    Publisher
    Frontiers Media S.A.
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://dx.doi.org/10.3389/fimmu.2018.01305
    Abstract
    Human gamma delta T cells have extraordinary properties including the capacity for tumor cell killing. The major gamma delta T cell subset in human beings is designated Vγ9Vδ2 and is activated by intermediates of isoprenoid biosynthesis or aminobisphosphonate inhibitors of farnesyldiphosphate synthase. Activated cells are potent for killing a broad range of tumor cells and demonstrated the capacity for tumor reduction in murine xenotransplant tumor models. Translating these findings to the clinic produced promising initial results but greater potency is needed. Here, we review the literature on gamma delta T cells in cancer therapy with emphasis on the Vγ9Vδ2 T cell subset. Our goal was to examine obstacles preventing effective Vγ9Vδ2 T cell therapy and strategies for overcoming them. We focus on the potential for local activation of Vγ9Vδ2 T cells within the tumor environment to increase potency and achieve objective responses during cancer therapy. The gamma delta T cells and especially the Vγ9Vδ2 T cell subset, have the potential to overcome many problems in cancer therapy especially for tumors with no known treatment, lacking tumor-specific antigens for targeting by antibodies and CAR-T, or unresponsive to immune checkpoint inhibitors. Translation of amazing work from many laboratories studying gamma delta T cells is needed to fulfill the promise of effective and safe cancer immunotherapy. Copyright 2018 Pauza, Liou, Lahusen, Xiao, Lapidus, Cairo and Li.
    Sponsors
    American Gene Technologies International, Inc. (AGT) is a privately held corporation. RL was funded by a grant from AGT to test gamma delta T cell immunotherapy for cancer in murine models and is supported by the Marlene and Stewart Greenebaum Comprehensive Cancer Center award from the National Cancer Institute (P30 CA134274, Kevin Cullen, MD Principal Investigator). CC is funded by the National Institute of Allergy and Infectious Disease for research on pediatric gamma delta T cells (R01 AI104702, Cristiana Cairo, PhD Principal Investigator and U01 HD092308, Cristiana Cairo, PhD Principal Investigator).
    Keyword
    Cancer
    Gamma delta
    Immuno-oncology
    T cell
    Targeted immunotherapy
    Vdelta2 gamma delta T cells
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048296411&doi=10.3389%2ffimmu.2018.01305&partnerID=40&md5=7edec0c88c6eb98376dc5a4b8ed9f93f; http://hdl.handle.net/10713/9233
    ae974a485f413a2113503eed53cd6c53
    10.3389/fimmu.2018.01305
    Scopus Count
    Collections
    UMB Open Access Articles 2018

    entitlement

     
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.